Gilead Sciences (GILD) Cash from Operations (2009 - 2026)

Gilead Sciences (GILD) has reported Cash from Operations for 18 consecutive years, with 2544000000.0 the latest figure, recorded in Q1 2026.

• Cash from Operations for Q1 2026 came in at 2544000000.0, up 44.79% year-over-year; the trailing twelve-month figure through Mar 2026 was 10806000000.0 (up 4.24% YoY), and the FY2025 annual result was 10019000000.0, down 7.47% from the prior year.
• Cash from Operations was 2544000000.0 for Q1 2026 at Gilead Sciences, down from 3327000000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 4309000000.0 in Q3 2024 and troughed at 827000000.0 in Q2 2025.
• Average Cash from Operations over 5 years is 2380529411.76, with a median of 2219000000.0 recorded in 2024.
• The widest YoY moves for Cash from Operations: up 145.53% in 2024, down 43.33% in 2024.
• Over 5 years, Cash from Operations stood at 2567000000.0 in 2022, then dropped by 15.5% to 2169000000.0 in 2023, then surged by 37.16% to 2975000000.0 in 2024, then increased by 11.83% to 3327000000.0 in 2025, then fell by 23.53% to 2544000000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 2544000000.0 in Q1 2026, 3327000000.0 in Q4 2025, and 4108000000.0 in Q3 2025.